blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3621588

EP3621588 - OCULAR COMPOSITIONS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  18.08.2023
Database last updated on 15.06.2024
FormerGrant of patent is intended
Status updated on  11.04.2023
FormerExamination is in progress
Status updated on  24.03.2023
FormerGrant of patent is intended
Status updated on  04.12.2022
FormerExamination is in progress
Status updated on  05.03.2021
FormerRequest for examination was made
Status updated on  14.02.2020
FormerThe international publication has been made
Status updated on  16.11.2018
Formerunknown
Status updated on  25.05.2018
Most recent event   Tooltip24.05.2024Lapse of the patent in a contracting state
New state(s): IT		published on 26.06.2024 [2024/26]
Applicant(s)For all designated states
The Queen's University Of Belfast
University Road
Belfast, Antrim BT7 1NN / GB
[2020/12]
Inventor(s)01 / THAKUR, Raghu Raj Singh
School of Pharmacy
Queen's University of Belfast
Medical Biology Centre
97 Lisburn Road
Belfast Antrim BT9 7BL / GB
02 / JONES, David
Research & Enterprise Directorate The Queen's University of Belfast
63 University Road
Belfast Antrim BT7 1NF / GB
03 / SONAWANE, Rahul
School of Pharmacy
Queen's University of Belfast
Medical Biology Centre
97 Lisburn Road
Belfast Antrim BT9 7BL / GB
 [2023/38]
Former [2020/12]01 / THAKUR, Raghu Raj Singh
School of Pharmacy
Queen's University of Belfast
Medical Biology Centre
97 Lisburn Road
Belfast Antrim BT9 7BL / GB
02 / JONES, David
Research&Enterprise Directorate The Queen's University of Belfast
63 University Road
Belfast Antrim BT7 1NF / GB
03 / SONAWANE, Rahul
School of Pharmacy
Queen's University of Belfast
Medical Biology Centre
97 Lisburn Road
Belfast Antrim BT9 7BL / GB
Representative(s)FRKelly
Waterways House
Grand Canal Quay
Dublin D02 PD39 / IE
[N/P]
Former [2020/12]FRKelly
27 Clyde Road
Dublin D04 F838 / IE
Application number, filing date18724226.810.05.2018
[2020/12]
WO2018EP62181
Priority number, dateGB2017000746210.05.2017         Original published format: GB 201707462
[2020/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018206749
Date:15.11.2018
Language:EN
[2018/46]
Type: A1 Application with search report 
No.:EP3621588
Date:18.03.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 15.11.2018 takes the place of the publication of the European patent application.
[2020/12]
Type: B1 Patent specification 
No.:EP3621588
Date:20.09.2023
Language:EN
[2023/38]
Search report(s)International search report - published on:EP15.11.2018
ClassificationIPC:A61K9/00, A61K9/50, A61K9/51
[2020/12]
CPC:
A61K9/0051 (EP,US); A61K9/5192 (EP,US); A61K31/5377 (EP);
A61K31/573 (EP); A61K45/06 (US); A61K9/0024 (EP);
A61K9/0048 (EP); A61K9/5026 (US); A61K9/5031 (US);
A61K9/5089 (EP,US); A61K9/5138 (US); A61K9/5146 (US);
A61L27/26 (EP); A61L27/54 (EP); A61L2300/622 (EP);
A61L2300/624 (EP); A61L2430/16 (EP); B82Y30/00 (US);
B82Y40/00 (US); B82Y5/00 (US) (-)
C-Set:
A61L27/26, C08L67/04 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/12]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ZUSAMMENSETZUNGEN FÜR DAS AUGE[2020/12]
English:OCULAR COMPOSITIONS[2020/12]
French:COMPOSITIONS OCULAIRES[2020/12]
Entry into regional phase03.12.2019National basic fee paid 
03.12.2019Designation fee(s) paid 
03.12.2019Examination fee paid 
Examination procedure03.12.2019Examination requested  [2020/12]
03.12.2019Date on which the examining division has become responsible
18.06.2020Amendment by applicant (claims and/or description)
05.03.2021Despatch of a communication from the examining division (Time limit: M04)
02.07.2021Reply to a communication from the examining division
05.12.2022Communication of intention to grant the patent
23.03.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
12.04.2023Communication of intention to grant the patent
11.08.2023Fee for grant paid
11.08.2023Fee for publishing/printing paid
11.08.2023Receipt of the translation of the claim(s)
Fees paidRenewal fee
05.03.2020Renewal fee patent year 03
10.03.2021Renewal fee patent year 04
11.03.2022Renewal fee patent year 05
15.05.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT20.09.2023
CZ20.09.2023
EE20.09.2023
ES20.09.2023
FI20.09.2023
HR20.09.2023
IT20.09.2023
LT20.09.2023
LV20.09.2023
NL20.09.2023
PL20.09.2023
RO20.09.2023
RS20.09.2023
SE20.09.2023
SK20.09.2023
SM20.09.2023
NO20.12.2023
GR21.12.2023
IS20.01.2024
PT22.01.2024
[2024/26]
Former [2024/25]AT20.09.2023
CZ20.09.2023
EE20.09.2023
ES20.09.2023
FI20.09.2023
HR20.09.2023
LT20.09.2023
LV20.09.2023
NL20.09.2023
PL20.09.2023
RO20.09.2023
RS20.09.2023
SE20.09.2023
SK20.09.2023
SM20.09.2023
NO20.12.2023
GR21.12.2023
IS20.01.2024
PT22.01.2024
Former [2024/23]AT20.09.2023
CZ20.09.2023
EE20.09.2023
ES20.09.2023
FI20.09.2023
HR20.09.2023
LT20.09.2023
LV20.09.2023
NL20.09.2023
RO20.09.2023
RS20.09.2023
SE20.09.2023
SK20.09.2023
SM20.09.2023
NO20.12.2023
GR21.12.2023
IS20.01.2024
PT22.01.2024
Former [2024/20]FI20.09.2023
HR20.09.2023
LT20.09.2023
LV20.09.2023
NL20.09.2023
RS20.09.2023
SE20.09.2023
SM20.09.2023
NO20.12.2023
GR21.12.2023
IS20.01.2024
Former [2024/14]FI20.09.2023
HR20.09.2023
LT20.09.2023
LV20.09.2023
NL20.09.2023
RS20.09.2023
SE20.09.2023
NO20.12.2023
GR21.12.2023
Former [2024/10]FI20.09.2023
HR20.09.2023
LT20.09.2023
LV20.09.2023
RS20.09.2023
SE20.09.2023
NO20.12.2023
GR21.12.2023
Former [2024/09]FI20.09.2023
LT20.09.2023
SE20.09.2023
NO20.12.2023
GR21.12.2023
Former [2024/08]LT20.09.2023
NO20.12.2023
GR21.12.2023
Cited inInternational search[I]WO2007084418  (SURMODICS INC [US], et al) [I] 1-21 * the whole document * * claims 21-31 *;
 [A]EP2481399  (UNIV TOHOKU [JP]) [A] 1 * the whole document *;
 [XP]WO2017081154  (THE QUEEN'S UNIV OF BELFAST [GB]) [XP] 1-21 * the whole document * * examples 1-5; claims 36-38 *;
 [A]  - LU CHANGHAI ET AL, "Hydrogel containing silica shell cross-linked micelles for ocular drug delivery", JOURNAL OF PHARMACEUTICAL SCIENCES,, (20130201), vol. 102, no. 2, doi:10.1002/JPS.23390, pages 627 - 637, XP002766597 [A] 1 * the whole document *

DOI:   http://dx.doi.org/10.1002/jps.23390
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.